News FDA clears AI-powered digital test for early dementia The FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out on an iPad in five minutes.
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face